Furthermore, LDH levels in severely infected individuals with COVID-19 are compounded due to increased cytokine activity, and decreased monitoring of Hb and hemolytic markers in cases with hemolytic disorders and COVID-19 [76]. The gene discussed is GSTM1; the disease is COVID-19.